KM plot analysis on survival data of HCC patients showed that patients with higher expression of WT1 in tumour (greater than 1.3 FPKM, data from transcriptomic sequencing of TGCA database) exhibited lower median survival than those with lower expression of WT1 (less than 1.3 FPKM; Figure 5B, p=0.0356). The gene discussed is WT1; the disease is neoplasm.